Sanofi India is currently trading at Rs. 3521.20, up by 28.60 points or 0.82% from its previous closing of Rs. 3492.60 on the BSE.
The scrip opened at Rs. 3492.00 and has touched a high and low of Rs. 3585.70 and Rs. 3492.00 respectively. So far 585 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 3693.80 on 25-Sep-2014 and a 52 week low of Rs. 2500.00 on 17-Feb-2014.
Last one week high and low of the scrip stood at Rs. 3605.60 and Rs. 3347.75 respectively. The current market cap of the company is Rs. 8043.68 crore.
The promoters holding in the company stood at 60.40% while Institutions and Non-Institutions held 28.62% and 10.99% respectively.
Sanofi India has received an approval for selling its commercial premises, being five floors and corresponding car-parking spaces in the building known as Hoechst House situated at Nariman Point, Mumbai to Bright Star Investments and its Group companies for a total consideration of Rs 134.25 crore. The board of directors at their meeting held on November 11, 2014 has approved for the same.
Each floor admeasures 7,442 square feet carpet area and all the floors have presently been given out on leave and license basis by the company to various third parties. The transaction is expected to be completed in the quarter ending December 31, 2014.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |